Co-proxamol and suicide: A study of national mortality statistics and local non-fatal self poisonings

British Medical Journal

Volumn 326, Issue 7397, 2003, Pages 1006-1008

  Hawton, Keith ^a   Simkin, Sue ^a   Deeks, Jonathan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROPROPOXYPHENE PLUS PARACETAMOL; PARACETAMOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; DRUG FATALITY; FEMALE; HUMAN; INCIDENCE; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SCHOOL CHILD; SELF POISONING; SUICIDE;

EID: 0037994041     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.326.7397.1006     Document Type: Article

References (17)

1. Department of Health. National suicide prevention strategy for England. London: Department of Health, 2002.
2. Taylor SJ, Kingdon D, Jenkins R. How are the nations trying to prevent suicide? An analysis of national suicide prevention strategies. Acta Psychiatr Scand 1997;95:457-63.
3. Hawton K, Townsend E, Deeks JJ, Appleby L, Gunnell D, Bennewith O, et al. Effects of legislation restricting pack sizes of paracetamol and salicylates on self poisoning in the United Kingdom: before and after study. BMJ 2001;322:1203-7.
4. Oliver RG, Hetzel BS. Rise and fall of suicide rates in Australia: relation to sedative availability. Med J Aust 1972;2:919-23.
5. Committee on Safety of Medicines. Current problems 14. London: Committee on Safety of Medicines, 1985.
6. Dollery C. Therapeutic drugs. Edinburgh: Churchill Livingstone, 1999.
7. Young RJ, Lawson AA. Distalgesic poisoning - cause for concern. BMJ 1980;280:1045-7.
8. Hawton K, Fagg J, Simkin S, Bale E, Bond A. Trends in deliberate self-harm in Oxford, 1985-1995. Implications for clinical services and the prevention of suicide. Br J Psychiatry 1997;171:556-60.
9. Sellar C, Goldacre MJ, Hawton K. Reliability of routine hospital data on poisoning as measures of deliberate self poisoning in adolescents. J Epidemiol Community Health 1990;44:313-5.
10. Bialas MC, Reid PG, Beck P, Lazarus JH, Smith PM, Scorer RC, et al. Changing patterns of self-poisoning in a UK health district. QJM 1996;89:893-901.
11. Penttinen J. Back pain and risk of suicide among Finnish farmers. Am J Public Health 1995;85:1452-3.
12. Fishbain DA. The association of chronic pain and suicide. Semin Clin Neuropsychiatry 1999;4:221-7.
13. Hawton K, Houston K, Shepperd R. Suicide in young people: a study of 174 cases, aged under 25 years, based on coroners and medical records. Br J Psychiatry 1999;175:1-6.
14. Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, et al. Why patients choose paracetamol for self poisoning and their knowledge of its dangers. BMJ 1995;310:164-4.
15. Haigh S. 12 years on: co-proxamol revisited. Lancet 1996;347:1840-1.
16. Sykes JV, Hanks GW, Forbes K. Co-proxamol revisited. Lancet 1996;348:408.
17. Li Wan Po A, Zhang WY. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. BMJ 1997;315:1565-71.